Please ensure Javascript is enabled for purposes of website accessibility
Contact us Contact Us
EN
Home > Featured Products > Oncology Research > Melanoma

960 product results for "Melanoma"

Options+
Options
Confirm
  • Product types
    0 selected
    Antibodies (298)
    Stable Cell Lines (1)
    Assay Kit (419)
    Biosimilars (1)
    Proteins (75)
    Research Biosimilar (157)
  • Expression system
    0 selected
    HEK293T (1)
    Mammalian Cells (185)
    E. coli (35)
  • Target
    0 selected
    CD80/B7-1 & CD86/B7-2 (2)
    Basiliximab (1)
    Apamistamab (1)
    CD117/KIT (24)
    Ranibizumab (3)
    CD274/PD-L1 (81)
    CD366/TIM-3 (34)
    cGMP (1)
    Olokizumab (1)
    Ocaratuzumab (1)
    Favezelimab (1)
    CD86/B7-2 (26)
    Drozitumab (1)
    Spike glycoprotein E1 (2)
    Eldelumab (1)
    Sacituzumab (1)
    PDL1 & VEGF (1)
    CD274/PD-L1 & CD3E (1)
    CD3E (1)
    Emactuzumab (1)
    Imalumab (1)
    Zampilimab (1)
    CD80&IL2 (1)
    Disitamab (1)
    Marstacimab (1)
    Nivolumab (3)
    Atezolizumab (3)
    Sotrovimab (1)
    Retatrutide (1)
    gD/Envelope glycoprotein D (1)
    Utomilumab (1)
    A29L (6)
    EGFR & CD3E & PD-L1 & 4-1BB (1)
    B6R/SL-159 (1)
    Pogalizumab (1)
    Bimekizumab (1)
    Guselkumab (3)
    Amatuximab (1)
    CD274/PD-L1 & VEGFA (1)
    NP/Nucleocapsid (5)
    dsDNA (1)
    Belantamab (1)
    Tiragolumab (2)
    Obiltoxaximab (1)
    CD19 & PD-L1 & CD3E & CD137 (1)
    FLT1/VEGFR1 & CD274/PD-L1 (1)
    RBD (E484K) (1)
    TFF3 (1)
    Anifrolumab (1)
    Camidanlumab (1)
    Varisacumab (1)
    Tesidolumab (1)
    BSA (1)
    Sirukumab (1)
    VEGFA & B7-H1 / PD-L1 / CD274 (1)
    BRAF/B-Raf (5)
    TYR (1)
    Abatacept (1)
    Lexatumumab (1)
    dsRNA (1)
    Ipilimumab (2)
    CD274/PD-L1 & CD47/MER6 (1)
    gp100 peptide-HLA Complex (1)
    Golimumab (3)
    CD47/MER6 & CD274/PD-L1/B7-H1 (2)
    CD223/LAG3 (41)
    CD152/CTLA4 & CD134/OX40 (1)
    Lupartumab (1)
    Pertuzumab (3)
    RBD (Kappa) (1)
    Ascrinvacumab (1)
    Pembrolizumab (3)
    Avelumab (3)
    CD152/CTLA4 (86)
    Casirivimab (1)
    Daratumumab (3)
    β-D-Glucan (1)
    gC/Envelope glycoprotein C (1)
    Tezepelumab (1)
    IL6 (1)
    SARS-CoV-2 Neutralization Antibody (3)
    Tavolimab (1)
    TIGIT & CD274/PD-L1 (1)
    Ixekizumab (1)
    Suvizumab (1)
    RBD (Omicron/BA.4/BA.5) (1)
    Cusatuzumab (1)
    Anetumab (1)
    Blosozumab (1)
    CD274/PD-L1 & TGFBR2/TGFR-2 (1)
    Varlilumab (1)
    Glycoprotein (5)
    Teclistamab (1)
    Sarilumab (2)
    Trastuzumab (2)
    PD-L1 & TGF-Beta (1)
    Obinutuzumab (2)
    PD-L1 / VEGF-A (1)
    Daclizumab (1)
    Emibetuzumab (1)
    Protein A (1)
    Ziltivekimab (1)
    Carlumab (1)
    Indatuximab (1)
    Tigatuzumab (1)
    ATP7B (1)
    S100A14 (1)
    Lenzilumab (1)
    Semorinemab (1)
    Tremelimumab (1)
    CD274/PD-L1 & CD134/OX40 (1)
    T3E (1)
    S100A5 (4)
    Cixutumumab (1)
    Andecaliximab (1)
    Vofatamab (1)
    Gremubamab (1)
    RBD (Delta Plus) (1)
    Sintilimab (1)
    Durvalumab (3)
    Imdevimab (1)
    S100A4 (3)
    gC/UL44 (1)
    Magrolimab (1)
    RBD (Omicron/BA.5) (3)
    Lirilumab (1)
    Remtolumab (1)
    Vorsetuzumab (1)
    DCT (2)
    Romosozumab (1)
    CD274/PD-L1 & CD137/TNFRSF9 (1)
    Romiplostim (2)
    M/Matrix protein (2)
    Rituximab (1)
    Enoblituzumab (1)
    TYRP1 (3)
    Depatuxizumab (1)
    CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)
    Zanidatamab (1)
    Afutuzumab (1)
    Icrucumab (1)
    CD366/HAVCR2/TIM-3 (4)
    PDL1 (6)
    Crizanlizumab (1)
    TRP-1 & CD3e (1)
    Tanezumab (1)
    Human β Amyloid (1-42) (1)
    S100A6 (1)
    LAG-3 & PD-1 (1)
    S100A10 (4)
    TPP15 (1)
    Namilumab (1)
    Tilavonemab (1)
    CTLA4 & PD1 (2)
    Zalifrelimab (1)
    T-cell surface antigen T3/Leu-4 epsilon chain (1)
    Infliximab (2)
    Dalotuzumab (1)
    Mirzotamab (1)
    M1R (5)
    Semaglutide (2)
    Cinpanemab (1)
    Tislelizumab (1)
    Pacmilimab (1)
    CD274/PD-L1 & CD152/CTLA4 (1)
    CD223/LAG3 & CD279/PD-1 (4)
    Ifabotuzumab (1)
    Siltuximab (3)
    gD/US6 (1)
    Elezanumab (1)
    Etanercept (3)
    NP/Nucleoprotein (3)
    CD20/MS4A1 (3)
    Secukinumab (2)
    Foravirumab (1)
    Elotuzumab (1)
    Ontamalimab (1)
    Eculizumab (3)
    Talacotuzumab (1)
    Tirzepatide (2)
    Pasotuxizumab (1)
    Farletuzumab (1)
    S100A1 (2)
    SOX10 (3)
    S100A12 (1)
    Oxelumab (1)
    Losatuxizumab (1)
    Spike glycoprotein (RBD) (1)
    CD274/PD-L1 & CD28 & CD152/CTLA4 (1)
    Epcoritamab (1)
    Fluorescein & CD274/PD-L1 (1)
    Ibalizumab (1)
    S100a15a (1)
    Tocilizumab (3)
    Inclacumab (1)
    S100P (1)
    Human β Amyloid (1-40) (1)
    Cergutuzumab (1)
    KITLG/SCF (1)
    CD47/MER6 & PDCD1 / PD-1 / CD279 (1)
    Lorvotuzumab (1)
    Lintuzumab (1)
    TPP17 (1)
    Otilimab (1)
    Zagotenemab (1)
    IDO1 (2)
    CD274/PD-L1 & CD28 (1)
    T-cell surface glycoprotein CD3 epsilon chain (1)
    Figitumumab (1)
    Rosopatamab (2)
    TYR/Tyrosinase (2)
    Omburtamab (1)
    Evolocumab (1)
    CD366/TIM-3 & CD274/PD-L1 (1)
    Toripalimab (1)
    CD279/PD-1 & CD152/CTLA4 (4)
    Denosumab (3)
    US8/gE (1)
    Sibrotuzumab (1)
    HLA-A2-peptide (TDQVPFSV) Complex (1)
    RBD (6)
    RBD (Omicron/JN.1) (1)
    Codrituzumab (1)
    Mazdutide (2)
    NRAS (2)
    Rafivirumab (1)
    RBD (WT) (1)
    CD274/PD-L1 & TGFBR2 (1)
    Meplazumab (1)
    Mirikizumab (2)
    Aflibercept (1)
    Vibecotamab (1)
    Glycoprotein G (2)
    GP/Envelope glycoprotein (4)
    MLANA (4)
    Ganitumab (1)
    Mirvetuximab (1)
    Necitumumab (1)
    Zenocutuzumab (1)
    CD274/PD-L1/B7-H1 (5)
    Glofitamab (1)
    Ieramilimab (1)
    S100A13 (1)
    Tregalizumab (1)
    TRP-1 & CD47/MER6 (1)
    Adalimumab (3)
    S100A2 (1)
    TAU pT181 (1)
    Labetuzumab (1)
    B7-H1 / PD-L1 / CD274 & CD3E (1)
    Faricimab (1)
    TPP47 (1)
    TDP2 (1)
    Asp f 1/mitF (1)
    MITF (1)
    CD223 (1)
    Edrecolomab (1)
    S100A11 (2)
    S100A16 (1)
    Canakinumab (1)
    gG/US4 (2)
    PMEL17/ME20M (9)
    Tarextumab (1)
    H3L (3)
    Alirocumab (1)
    CD137/4-1BB & CD274/PD-L1 (3)
    CD79B (2)
    S100A8 (3)
    Nirsevimab (1)
    CD223/LAG3 & CD152/CTLA4 (1)
    Cetuximab (3)
    Letolizumab (1)
    Imlifidase (5)
    Spike glycoprotein E2 (2)
    Enfortumab (1)
    RBD (Delta) (3)
    Dupilumab (3)
    RBD (Omicron/KP.2) (1)
    Tibulizumab (1)
    HLA-A2-peptide (ITDQVPFSV) Complex (4)
    RBD (Alpha) (1)
    p-Tyr (1)
    Glembatumumab (1)
    Gevokizumab (1)
    Teprotumumab (1)
    VASH2/Vasohibin-2 (1)
    Bevacizumab (3)
    Panitumumab (3)
    EPO/Erythropoietin (1)
    cAMP (1)
    Ibritumomab (1)
    Benufutamab (1)
    Zanolimumab (1)
    Lacnotuzumab (1)
    Olaratumab (1)
    TRP-1 & CD134/OX40 (1)
    TAU pT217 (1)
    Tisotumab (1)
    Oleclumab (1)
    Nesvacumab (1)
    G/Major surface glycoprotein G (1)
    Milatuzumab (1)
    Befovacimab (1)
    VSIR/VISTA & CD274/PD-L1 (1)
    Natalizumab (2)
    Exenatide acetate (2)
    gB/Envelope glycoprotein B (1)
    Omalizumab (2)
    Frovocimab (1)
    E8L (5)
    CD274/PD-L1 & CD279/PD-1 (1)
    Palivizumab (3)
    CD47/MER6 & CD274/PD-L1 (2)
    sCD14 (1)
    Simlukafusp Alfa (1)
    Spike glycoprotein (10)
    CD340/ERBB2 (1)
    Astegolimab (1)
    LAG3 & PD-1 (1)
    Vunakizumab (1)
    HLA-A2-peptide (YLEPGPVT) Complex (4)
    Tosatoxumab (1)
    CD152/CTLA4 & CD279/PD-1 (1)
    RBD (Beta) (1)
    CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)
    Alacizumab (1)
    Balstilimab (1)
    Dilpacimab (1)
    CD278/ICOS (1)
    Brolucizumab (1)
    Serclutamab (1)
    S100B (9)
    Clazakizumab (1)
    S100A9 (4)
    Mosunetuzumab (1)
    Mavezelimab (1)
    CD80/B7-1 (20)
    Conatumumab (1)
    Tovetumab (1)
    CD279/PD-1 & CD274/PD-L1 (1)
    Certolizumab (2)
    Calprotectin (S100A8/9) (3)
    Cabiralizumab (1)
    CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)
    CD152/CTLA4 & CD274/PD-L1 (1)
    Vanucizumab (1)
    N/Nucleoprotein (1)
    PD-L1 & VEGF (1)
    Concizumab (1)
    Rolinsatamab (1)
    Navicixizumab (1)
    Bimagrumab (1)
    gE/Envelope glycoprotein E (1)
    CD175/Tn (10)
    Urelumab (1)
    Lodelcizumab (1)
    A35R (5)
    CD366/TIM-3 & CD279/PD-1 (2)
    Ustekinumab (3)
    Ivuxolimab (1)
    Afasevikumab (1)
    Suptavumab (1)
    F/Fusion glycoprotein F0 (5)
    Itolizumab (1)
    Ianalumab (1)
    CD274/PD-L1 & SLT-Ia (1)
    Spike Protein (Trimer) (2)
    Iscalimab (1)
    IL1RL1/ST2 (1)
    mitF/aspF1 (1)
    HLA-A2-peptide (KTWGQYWQV) Complex (2)
    RBD (Gamma) (1)
    Ramucirumab (1)
    Cetrelimab (1)
  • Species
    0 selected
    Felis catus (Cat) (9)
    Canis lupus familiaris (1)
    Cat (1)
    Mouse (24)
    Rat (1)
    Mus musculus (Mouse) (7)
    Tupaia chinensis (12)
    Canis lupus familiaris (Dog) (8)
    Homo sapiens (Human) (7)
    Neosartorya fumigata (1)
    Human (177)
    Dog (3)
  • Applications
    0 selected
    IF (8)
    in vivo CTLA-4 neutralization (2)
    Bioactivity: FACS (1)
    Research in vivo (4)
    FCM (152)
    in vivo intra-tumoral regulatory T cell depletion (2)
    Bioactivity: FACS (153)
    in vivo blockade (2)
    in vivo (2)
    SDS-PAGE (75)
    Blocking (2)
    Functional assay (158)
    Immunogen (75)
    IP (2)
    SPR (4)
    FuncS (18)
    Research in vivo (158)
    in vivo PD-L1 blockade (3)
    Bioactivity testing in progress (31)
    Neut (1)
    IFA (4)
    in vitro PD-L1 blockade (3)
    ELISA (844)
    Inhib (1)
    FACS (5)
    GICA (2)
    IHC-F (3)
    IHC (84)
    Functional assay (6)
    WB (165)
    Neutralization (2)
  • Reactivity
    0 selected
    Drosophila willistoni (1)
    Coturnix japonica (1)
    Rhesus macaque (1)
    Bovine (1)
    Kirsten murine sarcoma virus (1)
    Cat (1)
    Dog (13)
    Chicken (4)
    Homo sapiens (Human) (4)
    Mouse (81)
    Kryptolebias marmoratus (1)
    Pig (6)
    Macaca mulatta (1)
    Rat (16)
    Tupaia chinensis (4)
    Limanda limanda (1)
    Carassius auratus (1)
    Pongo abelii (2)
    Human (199)
    Bos taurus (8)
    Mesocricetus auratus (1)
    Neosartorya fumigata (1)
    Cavia porcellus (1)
    Broad-Spectrum (1)
    Monkey (5)
    Oryctolagus cuniculus (4)
    Monodelphis domestica (1)
    Cyprinus carpio (1)
    Callithrix jacchus (1)
    Avian retrovirus IC10 (1)
    Oryzias latipes (1)
    B7-H1 / PD-L1 / CD274 (1)
    Danio rerio (1)
    Drosophila grimshawi (1)
    Capra hircus (1)
    Avian rous-associated virus type 1 (1)
    Cynomolgus monkey (1)
    Xenopus laevis (1)
    Mus musculus (Mouse) (1)
  • Host species
    0 selected
    Chimeric (5)
    Alpaca (6)
    Rabbit (61)
    HEK293T (1)
    Human (157)
    Armenian Hamster (5)
    Rat (14)
    Humanized (34)
    Dog (2)
    Mouse (164)
  • Clonality
    0 selected
    Polyclonal (53)
    Monoclonal (398)
  • Conjugate
    0 selected
    PerCP (28)
    PE (28)
    Unconjugated (301)
    FITC (28)
    APC (28)

Quick access

Contact Us

  • +86-27-65523339

  • info@abinscience.com

  • Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China

  • linkedin
  • Ins
  • youtube
  • youtube
Copyright © 2026 abinScience. All Rights Reserved. All Products are for Research Use Only